Building AI-Driven Member Portals: Personalization through Big Data Pipelines

Parth Jani

Authors

Parth Jani Sr. Business System Analyst/Project Coordinator at CareSource, USA Author

Keywords:

Healthcare IT, Member Portals, AI Personalization, Big Data Pipelines, Hadoop, Apache Spark, Predictive Analytics, Digital Health Engagement, Healthcare Analytics, Machine Learning

Abstract

In the quickly developing healthcare sector, the development of digital experiences that not only inform but also really involve members becomes more and more crucial. This work presents a practical, artificial intelligence-driven method based on big data technologies such as Spark and Hadoop to produce more intelligent and customized member portals. We examine how artificial intelligence and machine learning gently modify each user's portal experience by providing health advice, plan recommendations, and notifications reflecting their specific background, behavior, and preferences. This transformation centers on a big data pipeline that gives intelligent content to the front-end portal in real-time. We present significant fresh insights obtained from earlier implementations before 2019 and draw attention to the designs of early pioneers in this sector. The report offers a comprehensive technical architecture from data intake to user interface delivery that healthcare payers and providers may use to increase their engagement platforms. The aim is to demonstrate how healthcare businesses should strike a balance between the abundance of data they get and the special, meaningful interactions current workers need.

References

Johnsen, Maria. The future of Artificial Intelligence in Digital Marketing: The next big technological break. Maria Johnsen, 2017.

Phillips-Wren, Gloria, and Angela Hoskisson. "An analytical journey towards big data." Journal of Decision Systems 24.1 (2015): 87-102.

Phillips-Wren, Gloria, Ralph Doran, and Kristen Merrill. "Creating a value proposition with a social media strategy for talent acquisition." Journal of Decision systems 25.sup1 (2016): 450-462.

Huang, Bevan E., Widya Mulyasasmita, and Gunaretnam Rajagopal. "The path from big data to precision medicine." Expert Review of Precision Medicine and Drug Development 1.2 (2016): 129-143.

Coronado, Adrian E., et al. "Enabling mass customization: extending build-to-order concepts to supply chains." Production Planning & Control 15.4 (2004): 398-411.

Guenole, Nigel, and Sheri Feinzig. "The business case for AI in HR." With Insights and Tips on Getting Started. Armonk: IBM Smarter Workforce Institute, IBM Corporation (2018).

Ransbotham, Sam, et al. "Artificial intelligence in business gets real." MIT sloan management review (2018).

Tripathi, Rashmi, et al. "Next-generation sequencing revolution through big data analytics." Frontiers in life science 9.2 (2016): 119-149.

Siddique, Saleha Saulat. The road to enterprise Artificial Intelligence: a case studies driven exploration. Diss. Massachusetts Institute of Technology, 2018.

Ward, R. Matthew, et al. "Big data challenges and opportunities in high-throughput sequencing." Systems Biomedicine 1.1 (2013): 29-34.

Banegas-Luna, Antonio-Jesús, José P. Cerón-Carrasco, and Horacio Pérez-Sánchez. "A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data." Future medicinal chemistry 10.22 (2018): 2641-2658.

Meldolesi, Elisa, et al. "Standardized data collection to build prediction models in oncology: a prototype for rectal cancer." Future Oncology 12.1 (2016): 119-136.

Robinson, Anthony C., et al. "Geospatial big data and cartography: research challenges and opportunities for making maps that matter." International Journal of Cartography 3.sup1 (2017): 32-60.

Williamson, Ben. "Educating Silicon Valley: Corporate education reform and the reproduction of the techno-economic revolution." Review of Education, Pedagogy, and Cultural Studies 39.3 (2017): 265-288.

Benstead-Hume, Graeme, Sarah K. Wooller, and Frances MG Pearl. "‘Big data’approaches for novel anti-cancer drug discovery." Expert Opinion on Drug Discovery 12.6 (2017): 599-609.